CD40LG and COVID-19: In a cohort of 74 mechanically ventilated COVID-19 patients, anti-cardiolipin IgG and/or IgM and/or anti-B2-glycoprotein-I (anti-B2-GP1) IgG were detected in 9 patients, but did not correlate with thrombosis or coagulopathy (42).